India will have to increase the production of COVID-19 vaccines in a big way if it hopes to achieve its coverage targets, Dr Randeep Guleria, chief of the All India Institute of Medical Sciences (AIIMS) has said. It must also complement this with a comprehensive strategy for procurement of doses from abroad, he said.